| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. | Director | Common Stock | 45,619 | $817,948 | $17.93 | 09 Feb 2026 | Direct |
| ADMA BIOLOGICS, INC. | Director | Stock Option (Right to Buy) | 17,730 | $59,581 | $3.66 | 09 Feb 2026 | Direct |
| Decibel Therapeutics, Inc. | Director | Common Stock | 0 | $5.03 | 25 Sep 2023 | Direct | |
| Decibel Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 25 Sep 2023 | Direct |